Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-15

Clinical Trial Update: Optic Nerve Head Strain as Biomarker for Glaucoma [NA]

View source ↗

Summary

This clinical trial is evaluating optic nerve head strain as a biomarker for open-angle glaucoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Glaucoma, Open-Angle | NA | Status: RECRUITING